Hen Egg White Protein Market to Reach US$28.72 Billion by 2033 as Japan Reprices Egg Supply, Protein Fractionation and Functional Performance

HYDERABAD, India - October 16, 2026 - The global Hen Egg White Protein Market reached US$22.11 billion in 2025 and is projected to reach US$28.72 billion by 2033, advancing at a 3.2% CAGR during 2026-2033. The more consequential commercial shift is happening below the level of whole egg white. Egg albumen is increasingly being separated into functional proteins and enzymes that perform specific jobs across food preservation, nutrition, diagnostics, pharmaceuticals and biotechnology, while repeated avian-influenza disruption is forcing processors to reassess how much value can be recovered from each kilogram of available egg raw material.

Japan sits at the intersection of those two forces. The country has a mature egg-processing industry and established expertise in high-value egg-derived ingredients, but recent poultry-health disruptions have exposed the vulnerability of relying on stable shell-egg availability. The resulting opportunity is moving toward shelf-stable powders, liquid-egg buffering, traceable protein fractionation and specialty ingredients whose economics depend more on functional performance than on bulk protein volume.

Request Executive Sample: https://www.datamintelligence.com/download-sample/hen-egg-white-protein-market?kailas

Recent Developments

- June 2026 - EVERY and Huvepharma expand capacity: The companies announced a fourfold increase in production capacity for OvoPro, an egg protein made through precision fermentation. EVERY said orders secured in the first four months of 2026 were 5.5 times its total 2025 order volume, with sales across retail, e-commerce and foodservice.

- June 2026 - India ships dried egg powder to Austria: APEDA facilitated the first commercial export of dried whole egg powder from Odisha, marking a new route for value-added egg products.

- July 2026 - ADM and EVERY plan U.S. production: The companies announced plans to begin commercial-scale production of OvoPro at ADM's Clinton, Iowa facility, bringing fermentation-made egg protein production into an established ingredient manufacturing site.

- September 2026 - U.S. egg output rebounds: USDA reported August egg production of 9.43 billion eggs, up 5% year over year. The average layer flock was also up 5%, to 383 million.

- September 2026 - USDA raises export outlook: The USDA's 2026 forecast for U.S. egg and egg-product exports rose to 272 million dozen-equivalent, reflecting higher production projections and international demand.

- July 2026 - Japan publishes its revised tariff schedule: Japan's schedule lists a 25% general duty for dried egg whites under the relevant tariff classification, a cost factor for importers assessing powder supply.

The Highest-Margin Egg White May Never Be Sold as Egg White

The market is commonly described around liquid and powder formats, but the more important economic distinction is between commodity albumen and separated functionality.

Hen egg white contains several commercially valuable proteins, including ovalbumin, lysozyme, avidin and ovotransferrin. Each can support a different value chain.

Lysozyme has antimicrobial properties and is used in food preservation, fermentation, pharmaceutical and laboratory applications. Avidin's exceptionally strong interaction with biotin gives it value in diagnostics and life-science research. Ovotransferrin binds iron and is being positioned around antimicrobial, antioxidant and nutritional functions. Ovalbumin remains the dominant structural protein and provides the foaming, gelation and binding characteristics associated with egg white.

The uploaded market analysis identifies lysozyme as the largest type segment, reflecting the breadth of applications extending beyond conventional food protein.

This alters plant economics.

An egg processor that sells pasteurized liquid albumen competes primarily on food-grade quality, freight and availability. A processor capable of isolating specialty proteins competes on purity, biological activity, process validation and application performance.

That difference can materially change the revenue generated from the same raw material.

Purchase This Exclusive Report: https://www.datamintelligence.com/buy-now-page?report=hen-egg-white-protein-market?kailas

Additional Benefits:
✅ Get Interactive Dashboard Access (With No Additional Cost)
✅ Three months of analyst support to answer queries related to the report.

Japan's Competitive Advantage Is Functional Separation, Not Protein Tonnage

Kewpie demonstrates how egg processing can move beyond standard food ingredients.

Its fine-chemicals portfolio includes egg white peptide EP-1, food-grade egg white lysozyme and albumin, among other egg-derived materials. EP-1 is produced by enzymatically degrading egg white protein and is designed to retain a balanced amino-acid composition while resisting heat coagulation.

Kewpie's food-grade lysozyme is separated and purified from chicken egg white and conforms to the Japanese Standard of Food Additives. Its applications include shelf-life improvement and microbial control in fishery products, meat products, chilled foods and confectionery.

This is commercially more important than simply selling additional egg powder.

Heat resistance, enzyme activity, solubility and preservation capability allow one egg-derived material to enter applications where conventional protein powder would have limited value.

The economic target therefore shifts from protein kilograms recovered per tonne of eggs toward functional value recovered per tonne of eggs.

Powder Is Becoming a Supply-Risk Instrument

Liquid egg white retains advantages where manufacturers require familiar processing behavior, but powder changes the inventory equation.

Drying extends shelf life, lowers refrigeration dependence and allows material to move over longer distances without the same cold-chain burden. Powder can also be standardized for particular functional requirements such as whipping, gel strength or protein concentration.

OVODAN's albumen portfolio illustrates this application-specific model. It offers separate High Whip and High Gel powders rather than treating dried egg white as one universal material. The High Whip grade is positioned for bakery and confectionery applications, while High Gel is designed for applications requiring stronger gelling and water binding.

Its organic high-gel albumen powder contains at least 80% protein and carries defined specifications for gel strength, moisture and microbiological performance.

This form of standardization matters when shell-egg prices are volatile.

A manufacturer holding qualified powder can protect production schedules without carrying the same perishability risk as liquid material. That inventory flexibility becomes especially valuable in bakery, confectionery, nutrition and export formulations with predictable production schedules.

Avian Influenza Is Now a Contract Design Issue

Supply disruption can no longer be treated only as a poultry-farm problem.

Egg-protein contracts increasingly need to account for raw-material geography, alternative production sites, farm traceability, available inventory and the supplier's ability to redirect production when a regional outbreak interrupts egg supply.

OVODAN explicitly positions its multinational processing footprint as a continuity mechanism. The group operates production facilities across Denmark, Germany, China and Venezuela and states that its geographic network allows egg-product supply to continue when individual markets are affected by avian influenza.

Bioseutica takes a different approach at the specialty-protein level. It states that egg white used for its lysozyme extraction comes from veterinary-monitored flocks and that individual lysozyme batches are traceable back to the laying farm and laying date.

These are increasingly commercial specifications rather than sustainability language.

Production geography, batch traceability and disease-control protocols influence whether a food, pharmaceutical or diagnostic manufacturer can qualify an egg-derived protein as a dependable long-term input.

Plant-Based Competition Is Forcing Egg Protein to Prove Functionality

The uploaded market analysis identifies plant-based substitutes and egg allergy as meaningful constraints.

The competitive response cannot rely solely on egg protein's amino-acid profile.

Plant proteins are improving rapidly in gelation, whipping, binding and texture. Kewpie's own HOBOTAMA development is an unusually clear example: an established egg company is simultaneously refining plant-based technology capable of reproducing scrambled-egg characteristics.

That raises the performance threshold for conventional egg ingredients.

Egg white retains substantial technical advantages in aeration, foam stability, heat setting, binding and gel formation, but those characteristics need to be sold quantitatively.

Bakery applications can compare overrun, foam stability and finished-product volume. Processed foods can compare gel strength and water retention. Nutrition products can evaluate amino-acid quality, solubility and sensory profile.

The ingredient premium becomes easier to defend when the specification describes what the protein does in production rather than simply stating that it comes from egg white.

Company Profiles

Kewpie Corporation

Kewpie has one of the deepest Japan-based platforms in egg utilization, spanning consumer foods, processed egg products and fine chemicals.

Its specialty portfolio demonstrates how an egg processor can extract several layers of value from the same biological raw material. Egg white is used not only as food protein but also as a source for egg white peptides, lysozyme and albumin, while other egg fractions are used in additional food, healthcare and cosmetic applications.

The company's EP-1 peptide platform retains the amino-acid characteristics of egg white while reducing molecular size and avoiding heat coagulation. Its lysozyme platform addresses microbial-control applications. Kewpie therefore provides an important benchmark for fractionation, application development and high-value utilization of egg co-products.

The strategic relevance is strengthened by Kewpie's simultaneous investment in egg alternatives. Its HOBOTAMA program shows that the company is developing both conventional egg functionality and technologies capable of replacing egg in selected applications, giving it visibility across both sides of the substitution risk.

Bioseutica

Bioseutica operates at the specialty-protein end of the market rather than as a conventional food-protein supplier.

The company has nearly 75 years of enzyme-manufacturing experience and produces egg-derived lysozyme, avidin, ovotransferrin and other proteins using proprietary processes. Its applications extend across food processing, pharmaceuticals, diagnostics, nutrition, medical devices and animal health.

Its pharmaceutical-grade lysozyme is manufactured from hen egg white under cGMP conditions, while its food-grade lysozyme is produced through solvent-free processing. Bioseutica also offers ovotransferrin and avidin for specialized applications where protein purity and biological activity matter more than bulk protein economics.

The competitive position is therefore built around high-purity fractionation and regulatory-grade functional proteins.

OVODAN EGG GROUP

OVODAN represents the industrial food-processing model.

Its albumen powders are spray dried and pasteurized, with grades engineered around specific functionality. High Whip supports bakery and confectionery aeration, while High Gel targets water binding and structured food applications.

The group has operated since 1942 and reports around 600 employees, activity in more than 60 countries and production facilities across multiple regions. Its business-continuity proposition is particularly relevant when avian influenza or local egg-market disruption restricts supply in one geography.

Its differentiation lies in functional standardization, industrial-scale processing and multi-country supply redundancy.

Merck KGaA / Sigma-Aldrich

Merck participates in the market through high-specification laboratory and biotechnology proteins rather than mainstream food ingredients.

Its Sigma-Aldrich portfolio includes chicken egg-white lysozyme products with defined protein purity and biological activity. One DNA-free lysozyme grade contains at least 90% protein and at least 39,000 units per milligram of protein, with quality controls specifically designed for microbiome and molecular biology research.

Other Calbiochem-branded chicken egg-white lysozyme products are standardized around specific enzymatic activity for cell-based and research applications.

Request a Customized Report According to Your Business Strategy: https://www.datamintelligence.com/customize/hen-egg-white-protein-market?kailas

Food-grade egg white will remain the volume foundation.

Bakery, confectionery, beverages, sports nutrition and functional foods rely on the familiar nutritional and technical properties of albumen. The source market analysis identifies egg white as a binder, thickener and emulsifier and highlights growing use across food and industrial applications.

The second profit pool is structurally different.

Lysozyme, avidin, ovotransferrin, purified ovalbumin and peptides can move into pharmaceutical, diagnostic, preservative and specialized nutritional applications where performance specifications are significantly tighter.

Japan is especially well positioned for this transition because it combines sophisticated food processing, biotechnology demand and an established culture of high-specification ingredient qualification.

Contact Us:
Sai Kiran
Business Development Manager
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About DataM Intelligence
DataM Intelligence is a global market research and business intelligence firm delivering actionable insights across healthcare, pharmaceuticals, chemicals, energy, technology, food, and industrial sectors. Through syndicated reports, custom research, consulting, and competitive intelligence services, the company helps organizations identify growth opportunities, navigate market challenges, and make informed strategic decisions in over 50+ countries worldwide.

This release was published on openPR.